Acanthosis nigricans

Overview

Acanthosis nigricans is a reaction pattern of the skin rather than an infection. The epidermis thickens and becomes hyperpigmented and velvety, often in flexural areas. The visible change cannot usually be scrubbed away and vigorous scrubbing can irritate the skin further. ^{[1] [2]}

The most common pathway involves high circulating insulin levels stimulating insulin-like growth factor receptors and keratinocyte growth. Other hormonal states, medications and genetic variants can produce similar skin changes. In rare paraneoplastic disease, tumor-derived growth factors may drive abrupt, extensive lesions. ^{[1] [2]}

AN is particularly common in people with obesity, prediabetes, type 2 diabetes and polycystic ovary syndrome. It can be an important external clue to metabolic risk, especially when it develops in a child or young adult with weight gain or a strong family history of diabetes. ^{[1] [2] [3]}

Symptoms and warning signs

The skin becomes brown, gray or black, thicker than surrounding skin and velvety to the touch. The back and sides of the neck, armpits and groin are classic sites. Skin tags, itching or odor may be present, but pain and ulceration are not typical. ^{[1] [2]}

A slowly developing patch associated with obesity is usually not urgent. A sudden, rapidly spreading eruption—especially involving the mouth, palms or soles, or occurring with unexplained weight loss—should prompt medical evaluation because a rare internal malignancy or another systemic cause must be considered. ^{[1] [2]}

Diagnosis

Dermatologists usually diagnose AN by appearance and distribution. The important next step is determining why it developed. History includes weight change, family history, menstrual or androgen symptoms, medication exposure and the tempo of onset; physical examination looks for other metabolic or endocrine signs. ^{[1] [2]}

Glucose or HbA1c testing is commonly appropriate when insulin resistance is suspected. Depending on the presentation, clinicians may evaluate lipids, blood pressure, thyroid function or reproductive hormones. Biopsy is rarely needed when the appearance is classic but can help if the diagnosis is uncertain. ^{[1] [2] [3]}

Confluent and reticulated papillomatosis, frictional hyperpigmentation, post-inflammatory pigmentation, terra firma-forme dermatosis and certain genetic or drug-related disorders can resemble AN. A clinician distinguishes them by texture, distribution, history and response to cleansing or treatment. ^{[2] [3]}

Causes, risk factors and clinical context

Obesity and insulin resistance are the dominant risk factors. AN is also seen with polycystic ovary syndrome and other endocrine disorders and can run in families. Some medicines, including high-dose niacin and certain hormonal or systemic therapies, can contribute. ^{[1] [2]}

Metabolic AN usually develops gradually and may persist for years. It can improve substantially when the underlying insulin resistance or weight improves, although residual pigmentation can remain. Cosmetic treatment works best when the systemic driver is also addressed. ^{[1] [2] [3]}

Complications and why the diagnosis matters

AN does not usually damage the skin deeply, but it can cause distress, stigma and friction symptoms. The more important consequences come from the associated metabolic disorder—such as progression from prediabetes to diabetes or cardiovascular risk factors. ^{[1] [2]}

The skin finding is benign in most people. Prognosis is determined by the underlying condition. Gradual obesity-associated AN often improves with metabolic health; abrupt malignant AN behaves according to the associated cancer and requires a very different work-up. ^{[1] [2] [3]}

Treatment and management

Treatment starts with the cause. Weight management, physical activity and treatment of prediabetes or diabetes can reduce insulin levels and improve lesions. If a medication is responsible, clinicians consider alternatives when medically appropriate. Endocrine disorders such as PCOS are managed according to their own guidelines. ^{[1] [2]}

Dermatologists may use keratolytic or retinoid creams and other topical treatments to improve texture or appearance, but results vary. Gentle skin care is preferred over harsh scrubbing. Treating odor, friction or secondary irritation can improve comfort even when pigmentation persists. ^{[1] [2] [3]}

Do not use bleaching products, caustic acids or aggressive scrubbing without professional guidance. The main clinical risk is not the pigment itself but missing an associated metabolic disorder or, in an atypical abrupt presentation, a rare systemic cause. ^{[1] [2]}

Follow-up, recovery and prevention

Follow-up depends on the underlying metabolic or endocrine diagnosis. Patients with prediabetes or high diabetes risk need ongoing glucose and cardiovascular-risk monitoring; the skin can be reassessed as a visible marker of longer-term metabolic change. ^{[1] [2]}

Preventing excessive weight gain and identifying insulin resistance early can reduce the likelihood or severity of metabolic AN. There is no prevention for every inherited or medication-related form, but medication review and routine metabolic care can reduce modifiable drivers. ^{[1] [2] [3]}

Special situations and care pathway

In children and adolescents, AN should be approached without blame: it is a biologic marker, not evidence of poor hygiene. In pregnancy or PCOS, endocrine context changes interpretation. In older adults with abrupt severe disease, the threshold for evaluating systemic illness is lower. ^{[1] [2] [3]}

A practical pathway is dermatologic recognition, metabolic screening, targeted endocrine or medication review, treatment of the underlying condition and optional topical therapy. Broader investigation is reserved for atypical, rapid or extensive presentations. ^{[1] [2]}

When to seek urgent medical care

Seek prompt evaluation for sudden widespread velvety thickening, involvement of the mouth or palms, unexplained weight loss or other systemic symptoms. Routine slowly progressive lesions can be assessed non-urgently but should still trigger metabolic risk review. ^{[1] [2]}

Sources

1. American Academy of Dermatology — Acanthosis nigricans: Overview
2. American Academy of Dermatology — Acanthosis nigricans: Signs and symptoms
3. American Academy of Dermatology — Acanthosis nigricans: Who gets and causes

This article is based on trusted medical sources and is awaiting clinician review. It is not a substitute for personalized medical advice.